研究团队发现，6个周期的LS-FMD饮食可以减缓啮齿类动物肾脏结构和功能恶化。最重要的是，这种饮食模式诱导了足细胞重编程，并恢复了肾脏的滤过结构。与自由进食的啮齿类动物相比，接受LS-FMD饮食干预的动物在6个周期后的第4周和第6周，白蛋白/肌酸比值 ...

The global market for complement 3 glomerulopathy (c3g) treatment is poised for steady growth, with a projected valuation of ...

数据表明， 早在治疗14天时即可观察到Fabhalta可减少C3G患者的蛋白尿，此结果具临床意义并持续至12个月。 在研究的开放标签阶段，切换至Fabhalta的受试者也表现出蛋白尿的减少。

During the trial, patients treated with Fabhalta experienced a significant reduction in proteinuria as early as two weeks.

A recent study has shown that the prevalence of glomerular damage in adults with various forms of sickle cell anemia is much higher than previously thought. Guasch and colleagues investigated the ...

Pegcetacoplan substantially reduced proteinuria in these potentially debilitating rare kidney diseases in a new phase 3 study ...

诺华（Novartis）日前在2024年美国肾脏学会（ASN）肾脏周会议上，展示了临床3期APPEAR-C3G研究的12个月数据。结果显示，在支持性护理基础上接受口服 ...

The kidney damage from C3 glomerulopathy happens when your body’s complement system goes into overdrive. Here’s how it impacts your kidneys.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

With full confidence in China, where Novartis recorded 17 percent growth last year, one of the fastest among all major ...

1 About C3 glomerulopathy (C3G) C3G is an ultra-rare, progressive kidney disease that initially presents mostly in children and young adults.3,4,9 Each year, approximately 1-2 people per ...